Holland & Knight Advises MedShift in $108M of Debt Financing
DALLAS (May 9, 2023) – Holland & Knight represented MedShift, LLC a leading medical technology provider based in North Carolina, in $108 million of new financing. The company caters to medical device manufacturers as well as individual medical practices and providers across various markets, including dermatology, gynecology, plastic surgery and medspa.
Holland & Knight counseled MedShift in connection with three separate debt financing transactions: a $45 million credit facility for general working capital, up to $35 million in equipment financing and a $28 million credit facility to MedShift’s equity investor.
The Holland & Knight team representing MedShift was led by Partner Arthur Lotz and Associate Alyssa McLeod, with assistance from Partner John Gilson.
More information on the transaction can be found here.
Holland & Knight's Healthcare & Life Sciences Industry Group, a cross-disciplinary team of more than 400 experienced attorneys, is the largest healthcare law practice in the United States, according to data submitted to Modern Healthcare. The firm’s healthcare attorneys advise on matters ranging from business, regulatory compliance and real estate to litigation, government enforcement and public policy issues.